COMMUNIQUÉS West-GlobeNewswire

Geron Announces New Board Leadership Structure
31/12/2018
CEO John A. Scarlett Appointed Chairman Karin Eastham Appointed Lead Independent Director MENLO PARK, Calif., Dec. 31, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced changes to the leadership [...]
Peter D. Meldrum (1947-2018)
31/12/2018
Myriad Salutes the Life and Achievements of Its Co-Founder SALT LAKE CITY, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) today announced that the company’s former CEO Peter Durkee Meldrum, age [...]
Chief Medical Director Kari Syrjänen will retire from Biohit Oyj
31/12/2018
Biohit Oyj 31.12.2018 12:00 Biohit’s management team member Chief Medical Director Kari Syrjänen will retire as planned 31 st of December 2018. Kari Syrjänen has been employed by Biohit since 2013. ”I would like to [...]
GW Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
31/12/2018
LONDON and CARLSBAD, Calif., Dec. 31, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing [...]
Imprimis Pharmaceuticals, Inc. Completes Name Change to Harrow Health, Inc.
31/12/2018
Harrow Health, Inc. Name Reflects the Company’s Commitment to the Future of Healthcare SAN DIEGO, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (formerly known as Imprimis Pharmaceuticals, Inc.) (NASDAQ: IMMY) [...]
Eve & Co Announces First Shipment of Dried Cannabis Product and Files Financial Results for the Three and Twelve Month Periods Ended October 31, 2018
31/12/2018
TORONTO, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce that it has completed its first shipment of dried cannabis product [...]
Arrayit Corporation Announces Chief Executive Officer Letter to Shareholders
31/12/2018
Sunnyvale, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces a letter to shareholders from Arrayit Chief Executive Officer Rene Schena. The [...]
Terveystalo Plc: Terveystalo appoints Petri Bono as Chief Medical Officer
31/12/2018
Terveystalo Plc Stock Exchange release 31 December 2018 at 11:45 a.m. EET Petri Bono, born 1970, M.D., Ph.D., has been appointed as Chief Medical Officer as of 1 February 2019. He becomes a member of the Terveystalo [...]
Rule 2.9 Announcement
31/12/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 31 December 2018 [...]
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
31/12/2018
Company Release no. 24/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 December 2018 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis [...]
Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Tadalafil Sublingual Tablet
29/12/2018
SAN DIEGO, Dec. 28, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its fast- [...]
MedMira Reports First Quarter Results
29/12/2018
HALIFAX, Nova Scotia, Dec. 28, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2018. Q1 FY2019 Financial Results Highlights Profit [...]
Veloxis Pharmaceuticals Announces Financial Calendar for 2019
28/12/2018
Company Release no. 23/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 28 December 2018 Veloxis Pharmaceuticals Announces Financial Calendar for 2019 Veloxis Pharmaceuticals A/S (OMX: VELO) today announced its [...]
Helix BioPharma Corp. Closes Final Tranche of Private Placement
28/12/2018
CAD2,262,000 in total private placement financings closed in December 2018 for a total of CAD6,424,800 in calendar 2018 RICHMOND HILL, Ontario, Dec. 28, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP [...]
AIT Nearing Definitive Agreement to License Commercial Rights of Its Novel Ventilator Compatible Nitric Oxide Generator and Delivery System for Use in the Hospital Setting in the United States and a Second Country
28/12/2018
AIT to receive up to $32.5 million in up-front and regulatory milestones Additionally, AIT to receive a 15%-20% royalty on annual gross profit Partner to receive rights to all indications at nitric oxide concentrations [...]
RUDDCO Inc. Announces the Addition of a Bio-chemist and Toxicologist to the Staff
28/12/2018
MIAMI, Dec. 28, 2018 (GLOBE NEWSWIRE) -- Ruddco Inc., a Florida based company in conjunction with Orange Hill Limited under a joint venture agreement, is announcing an expansion of cannabis operations and the opening of [...]
Emergent BioSolutions Announces Submission to FDA of Application Covering Emergency Use Authorization for NuThrax™
28/12/2018
GAITHERSBURG, Md., Dec. 28, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today the submission of an application to the U.S. Food and Drug Administration (FDA) for potential emergency use of [...]
Medtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference
28/12/2018
DUBLIN - December 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37th Annual J.P. Morgan Healthcare Conference in San Francisco. Omar Ishrak, [...]
American Cannabis Company, Inc. Announces Filing of Form 10-K
28/12/2018
DENVER, CO, Dec. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary [...]

Pages